Pulmatrix (PULM) EBT Margin (QoQ) (2014 - 2024)
Pulmatrix (PULM) EBT Margin (QoQ) (2014 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.60 Bn | 130.75 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.93 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn |
| 4 | Moderna | 56.22 Bn | 51.08 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.65 Bn | 28.34 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - |
| 10 | Pulmatrix | 5.62 Mn | 5.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -6.19 Mn |
| Sep 30, 2024 | -31,252.00 |
| Jun 30, 2024 | -16,324.00 |
| Mar 31, 2024 | -13,302.00 |
| Dec 31, 2023 | 28,253.00 |
| Sep 30, 2023 | -13,881.00 |
| Jun 30, 2023 | 9,476.00 |
| Mar 31, 2023 | -5,611.00 |
| Dec 31, 2022 | 1,695.00 |
| Sep 30, 2022 | 7,021.00 |
| Jun 30, 2022 | 8,873.00 |
| Mar 31, 2022 | 49,758.00 |
| Dec 31, 2021 | -15,796.00 |
| Sep 30, 2021 | -61,007.00 |
| Jun 30, 2021 | 13,124.00 |
| Mar 31, 2021 | -17,868.00 |
| Dec 31, 2020 | -6,221.00 |
| Sep 30, 2020 | 2,054.00 |
| Jun 30, 2020 | 7,527.00 |
| Mar 31, 2020 | 9,222.00 |